Status:
COMPLETED
Computed Tomography (CT) Reconstruction for Axillary Lymph Node Structure
Lead Sponsor:
Peking University
Conditions:
Invasive Breast Cancer
Eligibility:
FEMALE
Brief Summary
This is a prospective, single-center, non-randomized, non-controlled observational study.
Detailed Description
The negative predictive value of ultrasound for lymph node with neoadjuvant chemotherapy is low, magnetic resonance imaging (MRI) or PET/CT did not significantly improve specificity to axillary lymph ...
Eligibility Criteria
Inclusion
- Invasive breast cancer with axillary lymph node metastasis by confirmed by fine needle aspiration (FNA) or core needle biopsy (CNB).
- Underwent computed tomography (CT) reconstruction for assessment of axillary lymph node status before and after neoadjuvant chemotherapy (NAC).
- Attend the study voluntarily, sign the informed consent.
Exclusion
- Contradiction for adjuvant chemotherapy.
- Contradiction for proceeding surgery.
Key Trial Info
Start Date :
August 25 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2019
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT03247478
Start Date
August 25 2017
End Date
August 30 2019
Last Update
September 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Cancer Hospital
Beijing, Beijing Municipality, China, 100142